The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)–like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring
- 2 July 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 114 (1) , 26-32
Abstract
In the revised National Cancer Institute Working Group (NCI-WG)/International Workshop on Chronic Lymphocytic Leukemia (IWCLL) guidelines for CLL, CLL-like monoclonal B lymphocytosis (MBL) is defined as the presence of less than 5 × 109/L B lymphocytes in the peripheral blood. However, the concentration of MBL in the blood is extremely variable. MBL in subjects with lymphocytosis require treatment at a rate of 1.1% per year and present immunoglobulin (IG) gene features and similar to good prognosis CLL. Little is known about low-count MBL cases, accidentally found in the general population. We analyzed IGHV-D-J rearrangements in 51 CLL-like MBL cases from healthy individuals, characterized by few clonal B cells. Seventy percent of the IGHV genes were mutated. The most frequent IGHV gene was IGHV4-59/61, rarely used in CLL, whereas the IGHV1–69 gene was lacking and the IGHV4-34 gene was infrequent. Only 2 of 51 (3.9%) MBL cases expressed a CLL-specific stereotyped HCDR3. Therefore, the IG gene repertoire in low-count MBL differs from both mutated and unmutated CLL, suggesting that the detection of MBL in an otherwise healthy subject is not always equivalent to a preleukemic state. Detailed IG analysis of individual MBL may help to identify cases that necessitate continuous clinical monitoring to anticipate disease progression.Keywords
This publication has 30 references indexed in Scilit:
- Variation of hemoglobin levels in normal Italian populations from genetic isolatesHaematologica, 2008
- MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5×109L−1 but a B-cell lymphocyte count <5×109L−1?Leukemia Research, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Prevalence and natural history of monoclonal and polyclonal B‐cell lymphocytosis in a residential adult populationCytometry Part B: Clinical Cytometry, 2007
- Association between the Gene Encoding 5-Lipoxygenase–Activating Protein and Stroke Replicated in a Scottish PopulationThe American Journal of Human Genetics, 2005
- Isolates and their potential use in complex gene mapping effortsCurrent Opinion in Genetics & Development, 2004
- Novel Case-Control Test in a Founder Population Identifies P-Selectin as an Atopy-Susceptibility LocusThe American Journal of Human Genetics, 2003
- CD5-positive B cells in healthy elderly humans are a polyclonal B cell populationEuropean Journal of Immunology, 2000
- Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ‐line gene usageEuropean Journal of Immunology, 1997
- Clonal cell surface structures related to differentiation, activation and homing in B‐cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significanceEuropean Journal of Haematology, 1989